IMRX — Immuneering Corp · $124.2M cap

Immuneering Corp (IMRX) is a biotechnology company listed on US.

Use this IMRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Immuneering Corp even when a live quote feed is slow.

Immuneering Corp latest statements (FY2025)

Latest cached year on this hub. Full IMRX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$56.0M
  • Total Assets$232.0M
  • Total Debt$0
  • Free Cash Flow-$45.5M

IMRX recent filings